RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge is a research paper published in Translational research (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AI137472
National Institutes of Health
Grant: R01AI139092
National Institutes of Health
Grant: R01AI157975
National Institutes of Health
Grant: 5R01AI137472-03
Rational design and evaluation of novel mRNA vaccines against MERS-CoV
National Institutes of Health
Grant: 7R01AI157975-02
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
National Institutes of Health
Grant: 5R01AI139092-04
Structure-based design of coronavirus subunit vaccines
FWCI
1.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals